Medtech company Enovis has expanded its device portfolio with the addition of the Manafuse Bone Growth Stimulator.
The portable device is indicated for daily use in the noninvasive treatment of fresh fractures and fracture nonunion, according to a July 7 news release from the company.
The stimulator utilizes a low intensity pulsed ultrasound signal to help activate the body’s natural healing process.
The intended use of the device is for 20 minutes once daily for up to 343 days, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.